NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 56 filers reported holding NUVALENT INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $111,706,134 | +10.5% | 2,429,979 | +1.4% | 0.00% | 0.0% |
| Q2 2023 | $101,075,756 | +76.4% | 2,396,864 | +9.2% | 0.00% | +50.0% |
| Q1 2023 | $57,290,979 | -11.6% | 2,195,898 | +0.9% | 0.00% | 0.0% |
| Q4 2022 | $64,823,288 | +136.2% | 2,176,739 | +54.2% | 0.00% | +100.0% |
| Q3 2022 | $27,440,000 | +54.7% | 1,411,554 | +7.9% | 0.00% | 0.0% |
| Q2 2022 | $17,736,000 | +1.5% | 1,308,006 | +4.0% | 0.00% | – |
| Q1 2022 | $17,466,000 | -5.0% | 1,257,463 | +30.2% | 0.00% | – |
| Q4 2021 | $18,386,000 | +24.8% | 965,642 | +47.8% | 0.00% | – |
| Q3 2021 | $14,728,000 | – | 653,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,341,024 | $368,253,000 | 7.72% |
| Fairmount Funds Management LLC | 914,614 | $17,414,000 | 5.74% |
| Bain Capital Life Sciences Investors, LLC | 3,428,014 | $65,269,000 | 5.18% |
| VR Adviser, LLC | 803,951 | $15,307,000 | 2.09% |
| Boxer Capital, LLC | 1,210,192 | $23,042,000 | 0.90% |
| Avoro Capital Advisors LLC | 1,102,671 | $18,431,000 | 0.31% |
| BVF INC/IL | 448,512 | $8,540,000 | 0.31% |
| Logos Global Management LP | 134,650 | $2,563,000 | 0.26% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,180,696 | $22,480,000 | 0.23% |
| Perceptive Advisors | 1,500,000 | $28,560,000 | 0.22% |